Today: 29 April 2026
Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing
6 January 2026
1 min read

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

New York, Jan 6, 2026, 12:38 (EST) — Regular session

  • Regencell Bioscience Holdings shares rise about 18% in midday trade after a wide intraday swing
  • Company site shows no new press release since its Oct. 31 annual report filing
  • Investors look for any fresh filing or statement, with Jan. 16 options expiry next on the calendar

Regencell Bioscience Holdings Ltd shares rose 18.3% to $31.99 on Tuesday, after touching $34.40 earlier and sliding as low as $26.60. The Nasdaq-listed stock was last up $4.95 from Monday’s close of $27.04, with about 850,000 shares traded.

The move keeps the Hong Kong-based bioscience company on momentum traders’ radar at the start of 2026, after a run of outsized daily swings. In small, lightly followed stocks, rapid price shifts can draw more short-term flow — and just as quickly reverse when liquidity thins.

Regencell’s investor-relations site has not posted a new press release since Oct. 31, when it said it filed its Form 20-F annual report — the disclosure foreign companies file with U.S. regulators.

In that filing, Regencell said it received correspondence and a subpoena from the U.S. Department of Justice after volatility in its shares, and that the DOJ was investigating trading in the stock. The company also warned there was “substantial doubt” about its ability to continue as a going concern — accounting language that flags it may need more funding to keep operating — and reported a net loss of $3.58 million for the year ended June 30, 2025. SEC

Regencell was also among the biggest gainers in U.S. premarket trade on Monday, rising about 16% before the bell, as traders chased volatile movers, Barron’s reported.

Tuesday’s $7.80 intraday range has widened the gap between buyers and sellers, a setup that can magnify jumps when orders thin out. The shares have pushed back above $30, with the day’s high near $34 back in view.

But the swings cut both ways. Any update on the Justice Department probe, an equity raise to bolster cash, or a sudden drop in trading volume could hit the stock hard, and momentum trades often unwind as fast as they build.

Stock Market Today

  • METAWATER Analysts Boost Earnings Forecasts After Fiscal Year Results
    April 28, 2026, 10:25 PM EDT. METAWATER Co., Ltd. (TSE:9551) reported full-year results showing revenues of JP¥210 billion, 3.4% above forecasts, while earnings per share (EPS) matched analyst expectations. Following these results, five analysts raised their 2027 forecasts to JP¥220.7 billion in revenue and JP¥220 EPS, indicating a 5.2% and 5.0% increase respectively. The consensus price target jumped 17% to JP¥3,100, reflecting improved earnings outlook. Despite recent share declines of 7.5% post-report, analysts remain cautiously optimistic, noting that forecast revenue growth aligns closely with industry averages but slows from historic rates. Analyst price targets range from JP¥2,000 to JP¥3,800, suggesting moderate divergence in sentiment. Overall, the earnings upgrade underscores increased confidence in METAWATER's future profitability.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Boeing stock rises as Bernstein lifts target to $277, but 737 supply signals stay in focus
Previous Story

Boeing stock rises as Bernstein lifts target to $277, but 737 supply signals stay in focus

GOLD stock pops as gold price nears record after Gold.com seals Monex deal
Next Story

GOLD stock pops as gold price nears record after Gold.com seals Monex deal

Go toTop